article
2 December 2020 | By Jerome Boyd-Kirkup (Hummingbird Bioscience)
When it comes to developing antibody drugs, Dr Jerome Boyd-Kirkup and his team are not sticking to the classical playbook. Here, he explains how they use systems biology and immuno-engineering to remove the element of luck from biologic drug discovery and development.